Monday, January 9, 2017

BRIEF-Amag Pharmaceuticals enters into an agreement to develop and commercialize Rekynda

* Entered into an agreement for exclusive North American

rights to develop and commercialize Rekynda

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)